This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Novartis AG (NVS)

NYSE: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash and Equivalents 6.69B 5.55B 3.71B 5.32B
Receivables 10.06B 10.05B 12.37B 9.87B
Inventories 7.27B 6.74B 5.93B 6.09B
Other Current Assets 4.00B 3.09B 118.00M 2.58B
Total Current Assets 30.54B 28.00B 24.08B 26.68B
Property, Plant & Equipment, Gross 35.46B 32.77B 29.94B 28.96B
Accumulated Depreciation & Depletion 17.26B 15.83B 14.31B 13.12B
Property, Plant & Equipment, Net 18.20B 16.94B 15.63B 15.84B
Intangibles 27.84B 30.33B 31.97B 35.23B
Other Non-Current Assets 11.27B 10.46B 10.02B 10.63B
Total Non-Current Assets 95.71B 96.21B 93.41B 96.63B
Liabilities & Shareholder Equity
Total Assets 126.25B 124.22B 117.50B 123.32B
Accounts Payable 7.81B 7.11B 6.41B 4.79B
Short Term Debt 6.78B 5.94B 6.34B 8.63B
Other Current Liabilities 5.48B 7.90B 7.72B 9.53B
Total Current Liabilities 26.37B 24.05B 23.15B 24.66B
Long Term Debt 11.24B 13.78B 13.86B 14.36B
Deferred Income Taxes 6.90B 7.29B 6.76B 7.69B
Other Non-Current Liabilities 7.27B 9.88B 7.79B 6.84B
Minority Interest 117.00M 113.00M 132.00M 175.00M
Total Non-Current Liabilities 25.54B 31.07B 28.50B 35.46B
Total Liabilities 51.91B 55.12B 51.65B 60.12B
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 74.34B 69.09B 65.84B 63.20B
Common Par 0.00 0.00 0.00 0.00
Additional Paid In Capital 1.00B 1.00B 1.02B 957.00M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings 73.43B 68.18B 64.95B 62.36B
Treasury Stock -89.00M -92.00M -121.00M -125.00M
Other Equity Adjustments 0.00 0.00 0.00 0.00
Total Capitalization 85.58B 82.87B 79.70B 77.56B
Total Equity 74.34B 69.09B 65.84B 63.20B
Total Liabilities & Stock Equity 126.25B 124.22B 117.50B 123.32B
Total Common Shares Outstanding 2.43B 2.42B 2.41B 2.29B
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 280.11M 285.57M 338.93M 348.18M
Basic Weighted Shares Outstanding 2.44B 2.42B 2.38B 2.29B
Diluted Weighted Shares Outstanding 2.48B 2.44B 2.41B 2.29B
Number of Employees 135696 127724 123686 119418
Number of Part-Time Employees 0 0 0 0
NVS News

Analysts Ratings for NVS

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 5 4 4 4
Moderate Buy 0 0 0 0
Hold 2 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1

Brokerage Partners

NVS Chatter

Select the service that is right for you!

Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs